Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1001 of 1,261
  1. US 7723104

    Cancer specific promoters

    The Board of Regents of the University of Texas System · Granted May 25, 2010 · Expires May 20, 2030

    granted
  2. US 7723300

    Regulators of the non-genomic action of progesterone and methods of use

    UNIVERSITY OF CONNECTICUT · Granted May 25, 2010 · Expires May 20, 2030

    granted
  3. US 7723303

    Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted
  4. US 7723313

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted May 25, 2010 · Expires May 20, 2030

    granted
  5. US 7723317

    RNAi modulation of ApoB and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  6. US 7723322

    Fluoride carrier for positron emission tomography

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted
  7. US 7723344

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  8. US 7723375

    Metabolites of wortmannin analogs and methods of using the same

    Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted May 25, 2010 · Expires May 20, 2030

    granted
  9. US 7723432

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted May 25, 2010 · Expires May 20, 2030

    granted
  10. US 7723496

    Preventives/remedies for cancer

    Takeda Pharmaceutical Company Limited · Granted May 25, 2010 · Expires May 20, 2030

    granted
  11. US 7723472

    Extracellular matrix binding chimeric proteins and methods of use thereof

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted
  12. US 7723474

    Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted
  13. US 7723500

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted May 25, 2010 · Expires May 20, 2030

    granted
  14. US 7723512

    Oligonucleotides comprising a non-phosphate backbone linkage

    Alnylam Pharmaceuticals, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  15. US 7723340

    Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

    Pharmacopeia Drug Discovery, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  16. US 7722889

    Plasmodium liver stage antigens

    The United States of America as represented by the Secretary of the Army · Granted May 25, 2010 · Expires May 20, 2030

    granted
  17. US 7723328

    Methods of facilitating cell survival using neurotrophin mimetics

    The Regents of the University of California · Granted May 25, 2010 · Expires May 20, 2030

    granted
  18. US 7723470

    Glycopeptide derivatives and pharmaceutical compositions containing the same

    Theravance, Inc. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  19. US 7723111

    Activated dual specificity lymphocytes and their methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted May 25, 2010 · Expires May 20, 2030

    granted
  20. US 7723345

    Multicyclic amino acid derivatives and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted May 25, 2010 · Expires May 20, 2030

    granted
  21. US 7723096

    Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted May 25, 2010 · Expires May 20, 2030

    granted
  22. US 7718610

    Retrocyclins: antiviral and antimicrobial peptides

    The Regents of the University of California · Granted May 18, 2010 · Expires May 13, 2030

    granted
  23. US 7718769

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 18, 2010 · Expires May 13, 2030

    granted
  24. US 7718196

    Rapamycin-resistant T cells and therapeutic uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 18, 2010 · Expires May 13, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.